Understanding how social and environmental factors affect atopic dermatitis in urban adults
Official title: Atopic dermatitis in an urban adult population: identifying the role of social and environmental factors
Funded at University of Pennsylvania · NIH-11115772 · Data updated 2026-11-12
This study is looking at how things like your surroundings and social life affect adults with atopic dermatitis (AD) in urban areas, especially in North Philadelphia, to better understand how these factors impact the severity of the condition and the quality of life for people dealing with it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | July 1, 2022 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $592,591 |
| NIH project number | 5R01AR080039-04 |
| Project ID | NIH-11115772 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults with atopic dermatitis, especially those from racially and ethnically diverse backgrounds living in urban settings.
✕Less likely to help
Patients without atopic dermatitis or those living outside the targeted urban areas may not benefit from this research.
What this research studies
This research investigates the impact of social and environmental factors on atopic dermatitis (AD) among adults living in urban areas, particularly focusing on a diverse population in North Philadelphia. The study aims to create a cohort of adults with AD to explore how these factors contribute to the severity of the condition and the quality of life of affected individuals. By collecting individual-level data on social and environmental contexts, the research seeks to identify disparities in AD outcomes among different racial and ethnic groups. This comprehensive approach will help in understanding the broader implications of AD and inform future interventions.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of atopic dermatitis, particularly for underserved populations.
How similar studies have gone: While there is ongoing research into atopic dermatitis, this specific focus on social and environmental factors in an urban adult population is relatively novel.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Takeshita, Junko — University of Pennsylvania
- Study coordinator: Takeshita, Junko
Related research
Other NIH-funded projects on the same topics.
-
Stopping Atopic Dermatitis and Allergy: Preventing Food Allergy by Protecting the Skin
A large study in infants at high risk for allergies tests whether using a skin barrier cream together with early, proactive skin care can prevent peanut allergy and other food allergies.
-
SEAL Study: Preventing peanut allergy by protecting baby skin
This trial tests whether using a skin-emollient and proactive skin steroids early in life can prevent peanut allergy in high-risk infants.
-
SEAL Study: Prevent allergy by protecting the baby’s skin
A very young group of high-risk babies will try a early skin-care plan to reduce eczema and prevent peanut allergy.
-
Understanding how skin fungi affect atopic dermatitis in adults
A study will look at how the skin's fungal community influences atopic dermatitis in adults and whether this understanding could lead to new treatments.
-
Preventing eczema-related allergies by strengthening infants' skin barrier
This project will see if using a trilipid skin cream plus proactive mild topical steroids in infants with early dry skin or eczema lowers their chances of developing food allergies.
-
Personalized predictions for how atopic dermatitis may progress in kids and teens
A patient-friendly plan to forecast how early-onset eczema might evolve in children and young people using simple health clues and data from diverse settings.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.